Clinical Research Directory
Browse clinical research sites, groups, and studies.
Italian Observational Study on CAR-T Therapy for Lymphoma
Sponsor: Paolo Corradini
Summary
The goal of this observational study on chimeric antigen receptor T-cell therapy is to monitor the feasibility, efficacy, toxicity and biomarkers in a real life setting. Partecipants will be asked to agree to their clinical data collection and to partecipate to the optional biological study that aims to evaluate biomarkers of toxicity and response (clinical characteristics, cytokine profile, cellcomposition and type of the CAR-T cell product, lymphoma genomics). The study will evaluate even the disease response according to lugano criteria by PET and CT in routine clinical activity.
Official title: A Multicenter Prospective Observational Study on Chimeric Antigen Receptor (CAR) T-cell Therapy for Lymphoma: Monitoring Feasibility, Efficacy, Toxicity and Biomarkers in a Real Life Setting
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
5300
Start Date
2019-10-30
Completion Date
2029-12-31
Last Updated
2024-04-01
Healthy Volunteers
No
Conditions
Locations (1)
Fondazione IRCCS Istituto Nazionale Tumori
Milan, Italy